Pulmonx Corporation LUNG Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | 74.2%+0.2pp | 74%+0.1pp | 73.9%-0.4pp | 74.3%+0.7pp | |
| Operating margin | -59.3%+9.6pp | -68.9%+21.3pp | -90.2%+19.1pp | -109.3%-11.6pp | |
| Net margin | -59.7%+7.6pp | -67.3%+21.3pp | -88.6%+21.2pp | -109.8%-9.3pp | |
| EBITDA margin | -58.1%+9.0pp | -67.1%+20.8pp | -87.9%+18.5pp | -106.5%-10.5pp | |
| Free cash flow margin | -36.3%+3.1pp | -39.4%+16.6pp | -55.9%+30.5pp | -86.5%+6.6pp | |
| Returns | |||||
| Return on equity | -77.2%-21.9pp | -55.3%-10.6pp | -44.7%-10.7pp | -33.9%-10.7pp | |
| Return on assets | -37%-3.9pp | -33.1%-0.4pp | -32.8%-5.3pp | -27.5%-8.0pp | |
| Return on invested capital | -89.6%-25.3pp | -64.4%+10.5pp | -74.9%+18.6pp | -93.5%+30.5pp | |
| Efficiency | |||||
| Asset turnover | 0.6×+0.1× | 0.5×+0.1× | 0.4×+0.1× | 0.3×+0.1× | |
| Inventory turnover | 8.8×-1.4× | 10.2×+5.7× | 4.6×— | —— | |
| Liquidity | |||||
| Current ratio | 5.1×-0.5× | 5.6×-0.9× | 6.5×-2.6× | 9.1×-2.7× | |
| Quick ratio | 4.9×-0.6× | 5.5×-0.9× | 6.4×-2.5× | 8.9×-3.0× | |
| Cash ratio | 3.4×+0.8× | 2.6×+0.1× | 2.5×-2.7× | 5.3×-2.8× | |
| Leverage | |||||
| Debt-to-equity | 1×+0.4× | 0.7×+0.3× | 0.4×+0.3× | 0×0.0× | |
| Debt-to-assets | 0.4×+0.1× | 0.3×+0.1× | 0.2×+0.2× | 0×0.0× | |
| Interest coverage | -17×-0.6× | -16.5×+2.7× | -19.2×+35.8× | -55×+2.1× | |
| Per Share | |||||
| Book value per share | $1.33-39.4% | $2.19-29.6% | $3.12-25.0% | $4.15-22.4% | |
| Valuation | |||||
| Market capitalization | $54.91M-43.7% | $268.12M-45.2% | $489.31M+55.3% | $315.11M-73.3% | |
| Enterprise value | $50.17M-39.2% | $260.3M-44.9% | $472.32M+110% | $225.19M-78.5% | |
| Price / sales | 0.6×-0.5× | 3.2×-3.9× | 7.1×+1.3× | 5.9×-18.5× | |
| Price / book | 1.3×-0.2× | 3.1×-1.0× | 4.1×+2.1× | 2×-4.1× | |
| EV / sales | 0.6×-0.4× | 3.1×-3.8× | 6.9×+2.7× | 4.2×-17.5× | |
| Free cash flow yield | -50.1%-19.4pp | -12.3%-4.5pp | -7.9%+6.9pp | -14.7%-10.9pp | |
| Earnings yield | -90.6%-36.0pp | -21%-8.6pp | -12.4%+6.3pp | -18.7%-14.6pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Pulmonx Corporation's profit margins?
- Pulmonx Corporation (LUNG) runs a 75.5% gross margin and a -58.8% operating margin, with a -60.1% net margin.
- Where do Pulmonx Corporation's ratios come from?
- Every ratio is computed from Pulmonx Corporation's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
